| New |
| Code |
Description |
| A4435 |
Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each |
| G0455 |
Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen |
| G8927 |
Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer |
| G8938 |
Bmi is calculated, but patient not eligible for follow-up plan |
| J2212 |
Injection, methylnaltrexone, 0. 1 mg |
| L8605 |
Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies |
| G9203 |
Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c |
| G9204 |
Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given |
| G9205 |
Patient starting antiviral treatmentfor hepatitis c during the measurement period |
| G9206 |
Patient starting antiviral treatment for hepatitis c during the measurement period |
| G9207 |
Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c |
| G9208 |
Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given |
| G9209 |
Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment |
| G9210 |
Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for reasons documented by clinician (eg, patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons) |
| G9211 |
Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given |
| G6018 |
Ileoscopy,through stoma; with transendoscopic stent placement (includes predilation) |
| G6019 |
Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique |
| G6020 |
Colonoscopy through stoma; with transendoscopic stent placement (includes predilation) |
| G6021 |
Unlisted procedure, intestine |
| G6022 |
Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique |
| G6023 |
Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) |
| G6024 |
Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare tehnique |
| G6025 |
Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation) |
| G6027 |
Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed |
| G6028 |
Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) |
| A4337 |
Incontinence supply, rectal insert, any type, each |
| G9499 |
Patient did not start or is not receiving antiviral treatment for hepatitis C during the measurement period |
| G9547 |
Incidental CT finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm |
| G9548 |
Final reports for abdominal imaging studies with follow-up imaging recommended |
| G9550 |
Final reports for abdominal imaging studies with follow-up imaging not recommended |
| G9612 |
Photodocumentation of one or more cecal landmarks to establish a complete examination |
| G9613 |
Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.) |
| G9614 |
No photodocumentation of cecal landmarks to establish a complete examination |
| G9659 |
Patients greater than 85 years of age who did not have a history of colorectal cancer or valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, crohn's disease (i.e., regional enteritis), familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease, ulcerative colitis, abnormal finding of gastrointestinal tract, or changes in bowel habits |
| G9660 |
Documentation of medical reason(s) for a colonoscopy performed on a patient greater than 85 years of age (eg., last colonoscopy incomplete, last colonoscopy had inadequate prep, iron deficiency anemia, lower gastrointestinal bleeding, crohn's disease (i.e., regional enteritis), familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease, ulcerative colitis, abnormal finding of gastrointestinal tract, or changes in bowel habits) |
| G9661 |
Patients greater than 85 years of age who received a routine colonoscopy for a reason other than the following: an assessment of signs/symptoms of GI tract illness, and/or the patient is considered high risk, and/or to follow-up on previously diagnoses advance lesions |
| J0596 |
Injection, C1 esterase inhibitor (recombinant), ruconest, 10 units |
| J3380 |
Injection, vedolizumab, 1 mg |
| G9683 |
This code is for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder or dehydration (similar pattern); may only be billed once per day per beneficiary |
| G9711 |
Patients with a diagnosis or past history of total colectomy or colorectal cancer |
| G9775 |
Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively |
| G9776 |
Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason) |
| G9777 |
Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively |
| G9862 |
Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy < 10 years old, other medical reasons) |
| J2840 |
Injection, sebelipase alfa, 1 mg |
| S0285 |
Colonoscopy consultation performed prior to a screening colonoscopy procedure |
| G9933 |
Adenoma(s) or colorectal cancer detected during screening colonoscopy |
| G9935 |
Adenoma(s) or colorectal cancer not detected during screening colonoscopy |
| G9936 |
Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus |
| G9937 |
Diagnostic colonoscopy |
| J0565 |
Injection, bezlotoxumab, 10 mg |
| J1627 |
Injection, granisetron, extended-release, 0.1 mg |
